< Back to latest news & events

Twitter

Mr Justice Meade has revoked Bristol Myers Squibb’s European #patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate that relate

April 2022

Mr Justice Meade has revoked Bristol Myers Squibb’s European #patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate that relate to the compound Apixaban (ELIQUIS) for lack of #plausibility. Read more in our latest update: hgf.com/news/blockbust…

Latest updates

Event - 31st May 2022

Innovation & IP Forum and Awards 2022

HGF Partner & Patent Attorney Dr Vivien Verbrugge will be attending the Innovation & IP Forum and Awards 2022 on 31st May in Paris. The Innovation & IP Forum and …

Event details

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article
Event - 15th-16th June 2022

Managing IP's Intellectual Property and Innovation Summit 2022

HGF is a gold sponsor at the Managing IP’s Intellectual Property and Innovation Summit, Europe. The event will take place on 15-16th June in London. This year the event will …

Event details